In partnership with:
This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma
- Andrew J. Cowan, Phillip A. Stevenson, Ted A. Gooley, Shani L. Frayo, George R. Oliveira, Stephen D. Smith, Damian J. Green, Jennifer E. Roden, John M. Pagel, Brent L. Wood, Oliver W. Press, Ajay K. Gopal
- British Journal of Haematology, January 2017, Wiley
- DOI: 10.1111/bjh.14451